Search results
Showing 8176 to 8190 of 8887 results
Discontinued Reference number: GID-CGWAVE0773
Discontinued Reference number: GID-TA10502
Rheumatoid arthritis - adalimumab, etanercept and infliximab (sequential use) [ID18]
Discontinued Reference number: GID-TAG393
Discontinued Reference number: GID-TA11339
In development Reference number: GID-TA11689 Expected publication date: TBC
Discontinued Reference number: GID-HST10033
Lenvatinib with pembrolizumab for untreated recurrent or advanced endometrial cancer [ID3966]
Discontinued Reference number: GID-TA10851
LN-145 for treating recurrent, persistent or metastatic cervical cancer [ID3844]
Discontinued Reference number: GID-TA10728
Discontinued Reference number: GID-HST10032
Discontinued Reference number: GID-TA10910
Nivolumab for adjuvant treatment of localised renal cell carcinoma [ID6362]
Discontinued Reference number: GID-TA11421
In development Reference number: GID-TA11273 Expected publication date: TBC
Discontinued Reference number: GID-TA10880
Pembrolizumab with lenvatinib for untreated advanced melanoma [ID3948]
Discontinued Reference number: GID-TA10848
Discontinued Reference number: GID-TA10929